Obsessive-Compulsive Disorder (OCD) Clinical Trial
Official title:
A Non-Inferiority Trial of Metacognitive Therapy Versus Exposure and Response Prevention for Individuals With Obsessive-Compulsive Disorder
Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.
The purpose of this study is to investigate metacognitive therapy by Wells (1997) with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01949753 -
Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT02267629 -
Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT04042038 -
Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder
|
N/A | |
Completed |
NCT01368510 -
Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
|
N/A | |
Not yet recruiting |
NCT05422469 -
OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial
|
N/A | |
Active, not recruiting |
NCT03300947 -
Psilocybin for Treatment of Obsessive Compulsive Disorder
|
Phase 1 | |
Recruiting |
NCT02773082 -
Reclaimâ„¢ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Not yet recruiting |
NCT06360991 -
DBS for Treatment-resistant Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT03605316 -
Deep Electrical Neuromodulation in Obsessive-compulsive Disorder
|